S. Chris Pappas - Concepedia

Author

S. Chris Pappas

Also Known As

Chris S. Pappas, J. Watson, S C Pappas, S Pappas, S. C. Pappas, S. Chris Pappas, S. Pappas, S.C. Pappas, S.Chris Pappas, Sara‐Jane Pappas

106

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

National Institutes of Health University of Toronto National Institute of Diabetes and Digestive and Kidney Diseases Virginia Commonwealth University Mallinckrodt (United States)

About

S. Chris Pappas is an author at National Institutes of Health specializing in medicine, hepatology, and hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	21	1.8K
2	Social Sciences	2	2	159
3	Education	1	1	14
4	Health Sciences	1	1	31
5	Diabetes	1	1	31

S. Chris Pappas

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
The canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis E. Jenny Heathcote, Karen Cauch‐Dudek, Valery Walker, Hepatology HepatologyBiliary TractBiliary CancerLiver PhysiologyUrsodeoxycholic Acid Therapy	1994	442
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome Florence Wong, S. Chris Pappas, Michael P. Curry, New England Journal of Medicine	2021	421
Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1 Thomas Boyer, Arun J. Sanyal, Florence Wong, Gastroenterology HepatologyLiver PhysiologyPharmacologyAcute Liver FailureTerlipressin Plus Albumin	2016	302
Randomized trial of chlorambucil for primary biliary cirrhosis Jay H. Hoofnagle, Gary L. Davis, Daniel F. Schafer, Gastroenterology HepatologyBiliary TractLiver PhysiologyGastroenterologyPathology	1986	157
Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis Jay H. Hoofnagle, Reginald G. Hanson, Gerald Y. Minuk, Gastroenterology Adenine Arabinoside MonophosphateHepatologyControlled TrialViral HepatitisHepatitis B	1984	138
Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD) Samuel S. Lee, E. Jenny Heathcote, K. Rajender Reddy, Journal of Hepatology Viral PersistenceImmunologyAntiviral TherapyVirologyVirus-host Interaction	2002	132
Visual evoked potentials in a rabbit model of hepatic encephalopathy. I. Sequential changes and comparisons with drug-induced comas. Daniel F. Schafer, S. Chris Pappas, L.E. Brody, PubMed	1984	107
Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the <scp>OT</scp>‐0401 and <scp>REVERSE</scp> randomised clinical studies Arun J. Sanyal, Thomas Boyer, R. Todd Frederick, Alimentary Pharmacology & Therapeutics	2017	100
Hepatic microvascular changes associated with development of liver fibrosis and cirrhosis Igor A. Sherman, S. Chris Pappas, M. M. Fisher American Journal of Physiology-Heart and Circulatory Physiology	1990	98
Visual Evoked Potentials in a Rabbit Model of Hepatic Encephalopathy D. F. Schafer, S. Chris Pappas, L.E. Brody, Gastroenterology Physiological OpticNeurophysiologyNeuroanatomyMedicineVision Research	1984	97

Page 1